Sensitive HLA loss of heterozygosity detection reveals allele-specific neoantigen expansion as resistance mechanism to anti-PD-1 therapy

被引：0
|
作者：
Pyke, Rachel Marty [1 ]
Abbott, Charles [1 ]
Mellacheruvu, Dattatreya [1 ]
Zhang, Simo, V [1 ]
Bedi, Nikita [2 ]
Colevas, A. Dimitrios [2 ]
Sunwoo, John [2 ]
West, John [1 ]
Chen, Richard [1 ]
Boyle, Sean Michael [1 ]
机构：
[1] Personalis, Menlo Pk, CA USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-6678
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6678
引用
收藏
页数：2
相关论文
共 19 条
  • [1] Association of HLA loss of heterozygosity with allele-specific neoantigen expansion in response to immunotherapy.
    Pyke, Rachel Marty
    Abbott, Charles
    Dea, Steven
    Bedi, Nikita
    Colevas, A. Dimitrios
    Levy, Eric
    Zhang, Simo V.
    Snyder, Michael
    Mellacheruvu, Datta
    Sunwoo, John B.
    Chen, Richard
    Boyle, Sean Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] HLA allele-specific loss of heterozygosity detection using augmented exome capture approach.
    Pyke, Rachel Marty
    Abbott, Charles
    Zhang, Simo V.
    Mellacheruvu, Datta
    West, John
    Chen, Richard
    Boyle, Sean Michael
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 40 - 41
  • [3] Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
    George, Suzanne
    Miao, Diana
    Demetri, George D.
    Adeegbe, Dennis
    Rodig, Scott J.
    Shukla, Sachet
    Lipschitz, Mikel
    Amin-Mansour, Ali
    Raut, Chandrajit P.
    Carter, Scott L.
    Hammerman, Peter
    Freeman, Gordon J.
    Wu, Catherine J.
    Ott, Patrick A.
    Wong, Kwok-Kin
    Van Allen, Eliezer M.
    IMMUNITY, 2017, 46 (02) : 197 - 204
  • [4] In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy
    Arlauckas, Sean P.
    Garris, Christopher S.
    Kohler, Rainer H.
    Kitaoka, Maya
    Cuccarese, Michael F.
    Yang, Katherine S.
    Miller, Miles A.
    Carlson, Jonathan C.
    Freeman, Gordon J.
    Anthony, Robert M.
    Weissleder, Ralph
    Pittet, Mikael J.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (389)
  • [5] PTEN loss confers resistance to anti-PD-1 therapy in NSCLC by increasing tumor infiltration of T regulatory cells
    Exposito, Francisco
    Redrado, Miriam
    Houry, Maeva
    Hastings, Katherine
    Molero-Abraham, Magdalena
    Lozano, Teresa
    Solorzano, Jose L.
    Ortega, Julian Sanz
    Andradas, Vera
    Amat, Ramon
    Redin, Esther
    Leon, Sergio
    Legarra, Naroa
    Garcia, Javier
    Serrano, Diego
    Valencia, Karmele
    Robles-Oteiza, Camila
    Foggetti, Giorgia
    Felip, Enriqueta
    Lasarte, Juan J.
    Paz-Ares, Luis
    Zugazagoitia, Jon
    Politi, Katerina
    Montuenga, Luis M.
    Calvo, Alfonso
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumors
    Song, Qi
    Yang, Bo
    Sheng, Wei
    Zhou, Zishan
    Zhang, Tianfu
    Qin, Boyu
    Ji, Liyan
    Li, Pansong
    Wang, Dan
    Zhang, Xiaoling
    Sun, Shengjie
    Zhang, Guoqing
    Zhao, Xiao
    Gan, Quan
    Xiong, Qi
    Guan, Yanfang
    Xia, Xuefeng
    Yi, Xin
    Chen, Xiudi
    Guo, Wei
    Jiao, Shunchang
    IMMUNOTHERAPY, 2022, 14 (07) : 553 - 565
  • [7] Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
    Kakavand, Hojabr
    Jackett, Louise A.
    Menzies, Alexander M.
    Gide, Tuba N.
    Carlino, Matteo S.
    Saw, Robyn Pm
    Thompson, John F.
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    MODERN PATHOLOGY, 2017, 30 (12) : 1666 - 1676
  • [8] CORRELATES OF POOR RESPONSE TO NEOADJUVANT ANTI-PD-1 THERAPY IN HEPATOCELLULAR CARCINOMA (HCC) INCLUDE WNT PATHWAY ACTIVATION AND LOSS OF HLA EXPRESSION
    Kundu, Kunal
    Fiaschi, Nathalie
    Wang, Wei
    Kou, Baijun
    Magen, Assaf
    Hamon, Pauline
    Gnjatic, Sacha
    Schwartz, Myron
    Kamphorst, Alice
    Marron, Thomas
    Merad, Miriam
    Guo, Chunguang
    Thurston, Gavin
    Gupta, Namita
    Cygan, Kamil
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A721 - A721
  • [9] Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy
    da Silva, Ines Pires
    Lo, Serigne
    Quek, Camelia
    Gonzalez, Maria
    Carlino, Matteo S.
    Long, Georgina, V
    Menzies, Alexander M.
    CANCER, 2020, 126 (01) : 86 - 97
  • [10] Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastases
    Misato Ito
    Kosaku Mimura
    Shotaro Nakajima
    Katsuharu Saito
    Aung Kyi Thar Min
    Hirokazu Okayama
    Motonobu Saito
    Tomoyuki Momma
    Zenichiro Saze
    Mikio Ohtsuka
    Toshiyuki Yamamoto
    Koji Kono
    Cancer Immunology, Immunotherapy, 2022, 71 : 2293 - 2300
12